Boston Scientific Corporation (BSX)
-NYSE 9.54 
0.10(1.04%) Jun 18, 4:00PM EDT|After Hours
:
9.54 0.00 (0.00%) Jun 18, 5:36PM EDT
| Prev Close: | 9.64 |
|---|
| Open: | 9.64 |
|---|
| Bid: | 9.11 x 1500 |
|---|
| Ask: | 9.64 x 1200 |
|---|
| 1y Target Est: | 8.89 |
|---|
| Beta: | 1.26 |
|---|
| Next Earnings Date: | 24-Jul-13 |
|---|
| Day's Range: | 9.51 - 9.68 |
|---|
| 52wk Range: | 4.79 - 9.75 |
|---|
| Volume: | 12,205,354 |
|---|
| Avg Vol (3m): | 19,077,400 |
|---|
| Market Cap: | 12.88B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -3.28 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 3 Healthcare Stock Stories Starting a Tuesday Buzzat Wall St. Cheat Sheet(Tue, Jun 18)
- Boston Scientific Inc. (BSX): Today's Featured Health Services Laggardat TheStreet(Tue, Jun 18)
- BSX Commences U.S. INTREPID TrialZacks(Tue, Jun 18)
- 4 Stocks Pushing The Health Services Industry Downwardat TheStreet(Tue, Jun 18)
- Boston Scientific Vercise™ DBS System demonstrates Improvement In Motor Function For Patients With Parkinson's DiseasePR Newswire(Tue, Jun 18)
- InPlay: Boston Scientific begins patient enrollment in U.S. clinical trial for use of Cercise DBS system in treatment of Parkinson's diseaseBriefing.com(Mon, Jun 17)
- Boston Scientific Begins Patient Enrollment In U.S. Clinical Trial For Use Of Vercise™ DBS System In Treatment Of Parkinson's DiseasePR Newswire(Mon, Jun 17)
- Gloomy Prospects For Medical Device Companiesat Seeking Alpha(Sun, Jun 16)
- The 5 Best Medical Device Stocks of 2013at Motley Fool(Sat, Jun 15)
- S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian IndicesCNW Group(Fri, Jun 14)
- 1 Huge Opportunity for the Star Stent of the Futureat Motley Fool(Fri, Jun 14)
- Analyst Favorites With Strong Buyback Activity: Boston Scientific Ranks As a Top Pickat Forbes(Thu, Jun 13)
- Analyst Moves: DISCA, BSX, XLSat Forbes(Thu, Jun 13)
- Investors love the CEO merry-go-roundat CNNMoney.com(Tue, Jun 11)
- Boston Scientific Inc. (BSX): Today's Featured Health Care Winnerat TheStreet(Mon, Jun 10)
Key Statistics
| Forward P/E (1 yr): | 20.30 |
|---|
| P/S (ttm): | 1.82 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.41 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.10 |
|---|
| Mean Recommendation*: | 2.5 |
|---|
| PEG Ratio (5 yr expected): | 2.45 |
|---|
Business Summary
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. The company offers interventional cardiology products, including coronary stent systems used in the tre...
View More